• Impact This is how monkeypox breaks all the schemes about the disease in Europe

  • Risks "You also have to control pets, they can be a way for the virus to reach wildlife"

  • Contagions "I think that in second-generation infections, cases will begin to appear not only in male adults"

  • Background Previous warnings about monkeypox

  • Hoaxes Debunking Monkeypox Conspiracy Theories

Spain already has 200 doses of the vaccine to deal with the monkeypox outbreak.

The trickle of cases has not stopped since the first cases registered on May 19.

In yesterday's latest data update, the Carlos III Health Institute has received samples belonging to

439 suspected cases

of

monkeypox

or monkey pox and

has confirmed 225 positive cases.

During the meeting that the autonomies held yesterday with the Ministry in the

Public Health Commission

, the use of the vaccine was reported in a series of cases and it was realized that Spain already has a limited number of doses.

Some communities point out that

"it is desperate that no decision has been made yet

."

This is due to the fact that yesterday's appointment was informative about the monkeypox situation and the decisions will be made tomorrow, Thursday, in another meeting in which

the communities expect some firm decision-making.

While in Spain the doses are demanded, in

the United Kingdom

they live a different situation.

They have more than a thousand doses, but according to a study recently published in

Eurosurveillance

, among the contacts considered to be at high and medium risk,

only 14% of the close contacts and 69% of the health personnel had accepted the offer of vaccination

until May 24.

In a draft of the Vaccine Report, to which EL MUNDO has had access,

the candidates to receive the vaccine are already classified

.

It points out "its

role in infection control as post-exposure prophylaxis in close contacts

of confirmed or probable cases."

And it establishes

two scenarios in which the order of vaccine use is prioritized,

since the current number of vaccines is limited and the vaccination recommendation requires a two-dose schedule, so, in principle, barely a hundred people they could benefit.

The keys to the infection

Health.

Monkeypox: symptoms, how it is spread and keys to differentiate it from another disease

  • Writing: CRISTINA G. LUCIO |

    PILAR PEREZMadrid

Monkeypox: symptoms, how it is spread and keys to differentiate it from another disease

Health.

Who is protected against monkeypox?

  • Writing: CRISTINA G. LUCIOMadrid

Who is protected against monkeypox?

First, "

it is recommended to offer vaccination to people classified as close contacts of confirmed and probable cases

."

This group includes close contacts, direct contact with surfaces where there is a possibility of contagion by fomites during the infectious period, exposure or contact with percutaneous wounds, health professionals handling samples without adequate protection, and contact with corpses.

Here, it is emphasized that "

special emphasis will be placed on collecting information on people who may have had sexual relations in contexts of risk with the case

".

In the second scenario,

immunization will be offered to people at high risk of contacts

: people with immunosuppression, health professionals who have had a close contact, and laboratory personnel who handle samples from suspected or confirmed

monkeypox patients

.

Thus, in all these cases, according to the draft, "

a dose of vaccine will be offered

, preferably in the first four days after close contact with a confirmed or probable case to try to avoid the disease, and the recommendation may be extended up to 14 days after the contact to reduce, probably, their symptoms".

In addition, "if there is a sufficient supply of vaccines,

vaccination will be completed with a second dose 28 days

after the first dose administered, in those people who do not have a history of vaccination against smallpox. In the event that they have

a history of vaccination, it will be assessed if

the administration of a second dose is necessary".

The United Kingdom will force the notification of the infection

While in the United Kingdom, where the first cases emerged in Europe,

monkeypox has been classified as a "notifiable infectious disease"

in a new effort by the United Kingdom Health and Safety Agency (UKHSA) to contain the spread of the zoonotic virus.

Step that Sweden already took before the first case found.

According to the last count,

they already add a total of 302 infections.

This represents a

new effort by the health agency to contain the spread of the zoonotic virus.

The regulations will come into force today, after the review the previous day of the Health Protection Act, 2010, and

will force doctors and laboratories in England

to report each suspected case and positive test results.

"Rapid communication and diagnosis

is critical to interrupting transmission and containing the spread

of monkeypox," said UKHSA expert Wendi Shepherd.

The measure is currently limited to England (Public Health matters have been transferred to regional administrations), where infections also prevail.

A total of 302 infections had been confirmed across the country as of June 5

, according to the latest official data.

Of these, 287 are located in England, ten in Scotland, three in Wales and two in Northern Ireland.

Most of those affected are gay or bisexual men, with no travel connections to countries where the virus is endemic.

In England, monkeypox will now be

subject to health controls for contagious diseases,

such as measles, mumps, malaria, scarlet fever, tuberculosis and typhus, among others that have been reported incidents in the last week.

Both GPs and laboratories testing for zoonotic infection are required to report suspected or confirmed cases to local or regional authorities.

The new classification will

speed up the collection of data from this outbreak of zoonotic infection

, which was detected in early May in the United Kingdom.

For now,

studies have confirmed the community transmission of the virus and its prevalence in homosexual environments

, among other points, but little has emerged about the origin, routes of transmission and possible links between the confirmed cases in Europe.

Conforms to The Trust Project criteria

Know more

  • monkey pox

  • Vaccines

  • United Kingdom

  • Europe